Immunoclin Corp

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$28.1M

10 transactions

Summary

Immunoclin Corp is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: —Sales: $05 insiders

Date	Insider	Type	Value
2015-06-10	Benlhassan Khadija(Chief Scientific Officer)	A	$10.0M
2015-06-05	JOHNSON CHAD STEVEN(Secretary/COO/General Counsel)	A	$5.0M
2015-06-05	Bray DH(President, CEO)	A	$4.0M
2015-06-05	Bray DH(President, CEO)	A	$4.0M
2014-11-01	MUNRO JAMES SCOTT(CFO, Treasurer)	A	$1.4M
2014-11-01	Bray DH(President, C.E.O.)	A	$1.4M
2014-11-01	Bray DH(President, CEO)	A	$1.4M
2015-01-01	JOHNSON CHAD STEVEN(Secretary/COO/General Counsel)	A	$725K
2015-01-30	Castor Management Services Inc.	Sell	$0
2015-01-30	Castor Management Services Inc.	Sell	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Immunoclin Corp — Contributions, Lobbying & Contracts | Poliscope